Kura Oncology (KURA) Non Operating Income (2014 - 2026)
Kura Oncology (KURA) reported Non Operating Income of $4.69 million for Q2 2026, down 28.4% from $6.54 million a year earlier and down 14.6% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Non Operating Income (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kura Oncology's Non Operating Income came in at $24.22 million, down 2.3% year-over-year; for FY2025, it came in at $25.26 million, up 19.0% from FY2024.
- Non Operating Income has increased for four consecutive years, with a five-year compound annual growth rate of 61.9% (FY2020 to FY2025).
- By year, Non Operating Income came in at $21.23 million in FY2024 (+61.2%), $13.17 million in FY2023 (+227.3%), $4.03 million in FY2022 (+408.2%) and $792,000 in FY2021 (-65.2%).
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Income since Q4 2023.
- Year over year, Non Operating Income gained in four of the last six quarters, with growth averaging 14.7%.
- The high point for year-over-year Non Operating Income in five years was Q1 2023 (growth of 659.0%); the low point was Q2 2026 (a decline of 28.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.69 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Jun 30, 2025 | 6.54 Mn |
| Mar 31, 2025 | 7.50 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 5.57 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 564,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 311,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Mar 31, 2021 | 202,000.00 |
API Access
Kura Oncology Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();